Company Rayont, Inc. Other OTC
Equities
RAYT
US75508M1009
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | Delta |
---|---|---|---|
Nutritional Supplements and Myotherapy
100.0
%
| 3 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | Delta |
---|---|---|---|
Australia
100.0
%
| 3 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 31/20/31 | |
Ilenna Copley
COO | Chief Operating Officer | - | 16/22/16 |
Dhurata Toli
BRD | Director/Board Member | 48 | 25/21/25 |
Paul Smith
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jason Sunstein
BRD | Director/Board Member | 52 | 21/22/21 |
Dhurata Toli
BRD | Director/Board Member | 48 | 25/21/25 |
Chief Executive Officer | 48 | 31/20/31 | |
Mark van Wyk
BRD | Director/Board Member | - | 21/22/21 |
Thea Dillon
BRD | Director/Board Member | - | 21/22/21 |
Bedri Thartori
CHM | Chairman | - | 23/23/23 |
Director/Board Member | - | 23/23/23 | |
Nara Chan
BRD | Director/Board Member | - | 23/23/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 50,163,797 | 24,169,968 ( 48.18 %) | 0 | 48.18 % |
Company contact information
Rayont, Inc.
228 Hamilton Avenue 3rd floor
94301, Palo Alto
+
Sector
1st Jan change | Capi. | |
---|---|---|
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+47.02% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |